Source:http://linkedlifedata.com/resource/pubmed/id/13225089
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-6
|
pubmed:dateCreated |
1955-12-1
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/AMEBIASIS/therapy,
http://linkedlifedata.com/resource/pubmed/keyword/CHLOROQUINE/therapeutic use,
http://linkedlifedata.com/resource/pubmed/keyword/DIIODOHYDROXYQUINOLINE/therapeutic...,
http://linkedlifedata.com/resource/pubmed/keyword/QUINACRINE/therapeutic use
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:pagination |
13-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:articleTitle |
[Baskir Kuba compound, new specific drug against intestinal and extra-intestinal amebiasis].
|
pubmed:publicationType |
Journal Article
|